Testing effectiveness (Phase 2)Study completedNCT03829475
What this trial is testing
ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI
Who this might be right for
Inflammatory Bowel DiseasesClostridium Difficile Infection
Brigham and Women's Hospital 61